X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29) 29
psychiatry (26) 26
index medicus (24) 24
female (16) 16
male (16) 16
adolescent (15) 15
double-blind (12) 12
pharmacology & pharmacy (12) 12
adult (11) 11
antipsychotic agents - therapeutic use (10) 10
drug therapy (10) 10
pediatrics (10) 10
treatment outcome (10) 10
antipsychotic agents - adverse effects (9) 9
double-blind method (9) 9
schizophrenia (9) 9
aggression (8) 8
major depressive disorder (8) 8
child (7) 7
clinical neurology (7) 7
piperazines - adverse effects (7) 7
piperazines - therapeutic use (7) 7
schizophrenia - drug therapy (7) 7
thiazoles - adverse effects (7) 7
thiazoles - therapeutic use (7) 7
adolescents (6) 6
middle aged (6) 6
psychiatric status rating scales (6) 6
aggression - psychology (5) 5
antipsychotic drugs (5) 5
antipsychotics (5) 5
bipolar disorder - drug therapy (5) 5
care and treatment (5) 5
children (5) 5
children & youth (5) 5
dosage and administration (5) 5
neurosciences (5) 5
rating-scale (5) 5
time factors (5) 5
young adult (5) 5
ziprasidone (5) 5
aged (4) 4
aggression - drug effects (4) 4
aggressiveness (4) 4
aggressiveness in adolescence (4) 4
antidepressive agents - therapeutic use (4) 4
atypical antipsychotics (4) 4
bipolar disorder (4) 4
depressive disorder, major - drug therapy (4) 4
original (4) 4
original articles (4) 4
practice guidelines (4) 4
psychotic disorders - drug therapy (4) 4
psychotropic drugs (4) 4
research (4) 4
risk factors (4) 4
aggressiveness in children (3) 3
analysis (3) 3
antipsychotic medications (3) 3
aripiprazole (3) 3
attention-deficit/hyperactivity disorder (3) 3
body weight - drug effects (3) 3
controlled trial (3) 3
deficit hyperactivity disorder (3) 3
desvenlafaxine (3) 3
dose-response relationship, drug (3) 3
guidelines (3) 3
mental depression (3) 3
mental disorders - drug therapy (3) 3
metabolic syndrome (3) 3
olanzapine (3) 3
open-label (3) 3
patient outcomes (3) 3
pediatric psychopharmacology (3) 3
primary-care (3) 3
psychology, developmental (3) 3
risperidone (3) 3
safety (3) 3
schizoaffective disorder (3) 3
studies (3) 3
usage (3) 3
2nd-generation antipsychotics (2) 2
abridged index medicus (2) 2
acute exacerbation (2) 2
adhd (2) 2
adherence (2) 2
adults (2) 2
aged, 80 and over (2) 2
antidepressants (2) 2
antipsychotic (2) 2
antipsychotic agents - administration & dosage (2) 2
attention deficit disorder with hyperactivity - drug therapy (2) 2
attention deficit hyperactivity disorder (2) 2
attitudes (2) 2
barriers (2) 2
best practice guidelines (2) 2
body mass index (2) 2
canadian network (2) 2
central nervous system stimulants - therapeutic use (2) 2
childhood-onset schizophrenia (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pediatrics, ISSN 0031-4005, 06/2012, Volume 129, Issue 6, pp. e1577 - e1586
Journal Article
Pediatrics, ISSN 0031-4005, 06/2012, Volume 129, Issue 6, pp. e1562 - e1576
Journal Article
Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 2009, Volume 48, Issue 5, pp. 501 - 510
Journal Article
Psychiatric Services, ISSN 1075-2730, 03/2007, Volume 58, Issue 3, pp. 342 - 348
Journal Article
International Journal of Neuropsychopharmacology, ISSN 1461-1457, 06/2013, Volume 16, Issue 5, pp. 987 - 995
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 11, pp. A1904 - A1904
Methods A retrospective cohort study of adults diagnosed with MDD following an initial MI or stroke diagnosis was conducted using the Truven Health MarketScan... 
Stroke | Hazards | Mental depression | Angina pectoris | Cardiovascular diseases | Health risk assessment | Heart diseases
Journal Article
Journal Article
Current Medical Research and Opinion, ISSN 0300-7995, 12/2019, Volume 35, Issue 12, pp. 2169 - 2177
Background: Guidelines recommend selective serotonin reuptake inhibitors (SSRI) and serotonin norepinephrine reuptake inhibitors (SNRI) as first-line... 
treatment initiation | cost | resource utilization | Major depressive disorder | Index Medicus
Journal Article
The International Journal of Neuropsychopharmacology, ISSN 1461-1457, 9/2011, Volume 14, Issue 8, pp. 1017 - 1027
Journal Article